Business Description
MYND Life Sciences Inc
NAICS : 325412
SIC : 3741
ISIN : CA62857B1094
Share Class Description:
XCNQ:MYND: Ordinary SharesCompare
Compare
Traded in other countries / regions
MYND.CanadaMYNDF.USA IPO Date
2021-05-26Description
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -6.94 | |||||
| Debt-to-Equity | -0.56 | |||||
| Debt-to-EBITDA | -6.44 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.8 | |||||
| 9-Day RSI | 65.25 | |||||
| 14-Day RSI | 58.01 | |||||
| 6-1 Month Momentum % | 50 | |||||
| 12-1 Month Momentum % | -40 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.13 | |||||
| Quick Ratio | 0.13 | |||||
| Days Payable | 1867.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -28.17 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -186.9 | |||||
| ROIC % | -48.91 | |||||
| ROC (Joel Greenblatt) % | -1410.71 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -9.35 | |||||
| EV-to-EBITDA | -9.52 | |||||
| EV-to-FCF | -17.74 | |||||
| Earnings Yield (Greenblatt) % | -10.7 | |||||
| FCF Yield % | -17.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MYND Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.02 | ||
| Beta | 0 | ||
| Volatility % | 174.64 | ||
| 14-Day RSI | 58.01 | ||
| 14-Day ATR (C$) | 0.00179 | ||
| 20-Day SMA (C$) | 0.025 | ||
| 12-1 Month Momentum % | -40 | ||
| 52-Week Range (C$) | 0.005 - 0.1 | ||
| Shares Outstanding (Mil) | 47.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MYND Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MYND Life Sciences Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
MYND Life Sciences Inc Frequently Asked Questions
What is MYND Life Sciences Inc(XCNQ:MYND)'s stock price today?
The current price of XCNQ:MYND is C$0.03. The 52 week high of XCNQ:MYND is C$0.10 and 52 week low is C$0.01.
When is next earnings date of MYND Life Sciences Inc(XCNQ:MYND)?
The next earnings date of MYND Life Sciences Inc(XCNQ:MYND) is .
Does MYND Life Sciences Inc(XCNQ:MYND) pay dividends? If so, how much?
MYND Life Sciences Inc(XCNQ:MYND) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers